|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for credit loss | |||||
| Amortization of debt discount and issuance costs | |||||
| Stock-based compensation expense | |||||
| Impairment of intangible assets | |||||
| Deferred income taxes | |||||
| Loss (gain) on mark-to-market adjustment of contingent consideration | |||||
| Expense on repurchase of convertible senior notes | |||||
| Other, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Other accrued expenses and current liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Payments for acquisition of businesses, net of cash acquired | |||||
| Capital expenditures | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Settlement of convertible senior notes | |||||
| Repurchase and retirement of common stock | |||||
| Proceeds from the exercise of common stock options | |||||
| Proceeds from employee stock purchase plan contributions | |||||
| Payments for repurchase and retirement of common stock | |||||
| Proceeds from issuance of convertible senior notes, net of underwriters' discounts and commissions | |||||
| Repurchase of convertible senior notes | |||||
| Payments for issuance costs of convertible senior notes | |||||
| Proceeds from private placement of common stock | |||||
| Payments on revolving commitment | |||||
| Borrowings under revolving commitment | |||||
| Other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Issuance of common stock in connection with acquisitions | |||||
| Promissory notes issued and deferred payment obligations for acquisitions and investments | |||||
| Property and equipment in accounts payable and other current liabilities | |||||
| Finance leases | |||||
Loading...